411 Obesity

I. Definition & Overview

  • Obesity: Defined as the excessive accumulation of adipose tissue which leads to:

    • Systemic inflammation

    • Neuroendocrine dysfunction

    • Increased risk for chronic diseases, including:

    • Type 2 diabetes

    • Hypertension

    • Cardiovascular disease

  • Key Distinctions in Body Fat:

    1. Visceral Fat:

    • Surrounds organs.

    • Metabolically harmful and linked to:

      • Insulin resistance

      • Inflammation

    1. Subcutaneous Fat:

    • Located just under the skin.

    • Less metabolically active than visceral fat.

    1. BMI Classification:

    • Normal: 18.5–24.9

    • Overweight: ≥25

    • Obese: ≥30

    • Morbidly Obese: ≥40

II. Etiology of Obesity

  • Genetic/Physiological Factors:

    • Differences in enzyme productivity

    • Variations in adipose storage capacity

    • Hormonal regulation involving hormones like leptin, adiponectin, and cortisol.

  • Behavioral Factors:

    • High energy intake

    • Low physical activity

    • Sedentary lifestyle

  • Environmental Factors:

    • Diet culture

    • Home and community habits influencing dietary choices

    • Lack of physical activity opportunities in schools

III. Pathophysiology Overview

  • Obesity as an Inflammatory Disease:

    • Key systems involved:

    • Hypothalamus

    • Adipose tissue

    • HPA (Hypothalamic-Pituitary-Adrenal) axis

    • These systems contribute to controlling energy balance, hunger, stress, and fat distribution.

1. Hypothalamic Inflammation

  • Triggered by diets high in sugar and fat leading to:

    • Inflammatory activation of hypothalamic neurons.

    • Disruption of normal satiety signals causing overeating and weight gain.

    • Development of leptin resistance where hunger persists despite adequate energy stores.

    • Increased secretion of cortisol, contributing to insulin resistance and systemic inflammation.

2. HPA Axis Activation

  • Chronic Stress Activation:

    • Increased secretion of cortisol due to:

    1. CRH (hypothalamus) → ACTH (pituitary) → Cortisol (adrenal cortex)

    • Effects of Cortisol:

    • Increases glucose availability, antagonizes insulin, leading to insulin resistance.

    • Prolonged cortisol elevation results in visceral fat accumulation.

    • Causes muscle wasting and impaired immunity.

    • Leads to hypertension and endothelial dysfunction due to sympathetic nervous system activation.

3. Chronic SNS Activation

  • Chronic stress results in ongoing high levels of norepinephrine and epinephrine leading to:

    • Redistribution of fat from subcutaneous to visceral storage.

    • Elevated blood pressure and increased energy storage despite a high caloric intake.

IV. Hormonal and Inflammatory Links (Adipokines & Cytokines)

Adipokine

Produced By

Key Actions

Changes in Obesity

Leptin

Adipocytes

Regulates satiety, metabolism, and HPA axis activity.

Elevated but exhibits resistance; fails to suppress appetite.

Adiponectin

Adipocytes

Improves insulin sensitivity and fatty acid oxidation.

Decreased levels lead to loss of anti-inflammatory effects.

TNF-α

Adipocytes & Macrophages

Pro-inflammatory; reduces insulin receptor signaling.

Overexpressed in obesity; contributes to insulin resistance.

IL-6

Visceral WAT

Mixed inflammatory role; regulates hepatic glucose output.

Levels increased, contributing to insulin resistance.

Resistin

Adipocytes/Macrophages

Reduces insulin sensitivity; promotes hepatic glucose production.

Elevated; reinforces inflammatory signaling pathways.

PAI-1

Visceral WAT

Inhibits fibrinolysis (pro-thrombotic).

Increased levels; contributes to cardiovascular disease risk.

Angiotensinogen (AGT)

Liver & WAT

Activates RAAS leading to vasoconstriction and increased BP.

Elevated linking obesity to hypertension.

V. Free Fatty Acids (FFA) and Metabolic Dysregulation

  1. Normal function involves WAT releasing FFAs during energy deficits.

  2. Insulin resistance leads to inadequate suppression of FFA release, resulting in:

    • Elevated plasma FFAs.

  3. High FFA levels promote:

    • Hepatic triglyceride synthesis → Hypertriglyceridemia.

  4. FFAs impair insulin signaling in:

    • Skeletal muscle

    • Liver

  5. FFAs are implicated in inducing endothelial dysfunction, promoting atherosclerosis.

VI. Chronic Stress–Fat–Inflammation Loop

  • Feedback Loop Driving Obesity Persistence:

    1. Stress activates the HPA axis → ↑ Cortisol

    2. Cortisol increases glucose levels → ↓ Insulin sensitivity

    3. Insulin resistance leads to increased lipolysis → ↑ Free Fatty Acids

    4. Elevated FFAs trigger release of pro-inflammatory cytokines (TNF-α, IL-6, resistin)

    5. Cytokines cause hypothalamic inflammation leading to increased hunger, repeating the cycle.

VII. Clinical Takeaways

  1. Leptin Resistance: A hallmark of obesity with implications on hunger regulation.

  2. Adiponectin Levels: Low levels are associated with higher insulin resistance and increased atherosclerosis risk.

  3. Visceral Adiposity: A significant driver of metabolic syndrome and is related to worse health outcomes.

  4. HPA Axis Overactivation: Directly links chronic stress to obesity and hypertension presentations.

  5. Elevated PAI-1 Levels: Contribute to increased pro-thrombotic states, highlighting cardiovascular risks.

  6. Leptin/Adiponectin Ratio: Serves as a strong indicator of cardiometabolic risk, offering insights into obesity-related disease susceptibility.